| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/02/2005 | CN1587390A Preparation and application of cell-eliminating pig corium substrate without cytotoxicity |
| 03/02/2005 | CN1587389A Separating and cultivating method for wistar rat stomach ICC |
| 03/02/2005 | CN1586428A Tooth regenerating technology using keratin cell stem cell and dental mesenchyme |
| 03/02/2005 | CN1191362C Streptococcus antigens |
| 03/02/2005 | CN1191361C Carrot anti-freeze polypeptides |
| 03/02/2005 | CN1191360C Modified clotting factor VIII |
| 03/02/2005 | CN1191357C Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 03/02/2005 | CN1191355C Process for preparing fowl paralysis virus using cntinuous avian cell line |
| 03/02/2005 | CN1191354C Method for producing transgene rice with amount of spikelet being increased |
| 03/02/2005 | CN1191347C Cleaning compositions contg. multiply-substd-protease variants |
| 03/02/2005 | CN1191276C Humanized antibodies and method for forming same |
| 03/02/2005 | CN1191271C Thymic peptide fusion protein as one new interferon and its prepn. |
| 03/02/2005 | CN1191270C Cellulose binding domain |
| 03/01/2005 | US6861578 Method for plant protection against insects or nematodes by transformation with a nucleic acid encoding equistatin |
| 03/01/2005 | US6861517 Nucleic acid fragments, recombinant vector containing the same and method for promoting the expression of structural gene by using the same |
| 03/01/2005 | US6861507 Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria |
| 03/01/2005 | US6861414 Methods for enhancing graft survival by modulating heme oxygenase activity |
| 03/01/2005 | US6861408 Therapeutic anti-melanoma compounds |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
| 03/01/2005 | US6861257 Methods for isolation of osteoclast precursor cells and inducing their differentiation into osteoclasts |
| 03/01/2005 | US6861256 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 03/01/2005 | US6861255 Method of using fish plasma components for tissue culture |
| 03/01/2005 | US6861242 Reacting glucosidase and phosphotransferase |
| 03/01/2005 | US6861236 Harvesting antibiotic peptides comprising transport protein leader sequences |
| 03/01/2005 | US6861234 Method of epitope discovery |
| 03/01/2005 | CA2114631C N-acetylglucosaminyltransferase v coding sequences |
| 02/25/2005 | CA2476143A1 Method for inducing cytotoxic t lymphocyte |
| 02/24/2005 | WO2005017167A1 Promoter molecules for use in plants |
| 02/24/2005 | WO2005017165A1 Stem cell beacon |
| 02/24/2005 | WO2005017164A1 Vigilant cells |
| 02/24/2005 | WO2005017163A2 Phenotypic knockout of cell-surface proteins |
| 02/24/2005 | WO2005017160A2 Mobilization of hematopoietic cells |
| 02/24/2005 | WO2005017152A1 Method of elevating transformation efficiency in plant by adding copper ion |
| 02/24/2005 | WO2005017151A1 End-deficient mutant of ip3 receptor protein inducing apoptosis |
| 02/24/2005 | WO2005017149A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | WO2005017132A1 Method of generating neural stem cells |
| 02/24/2005 | WO2005017131A2 Methods for the differentiation of human stem cells |
| 02/24/2005 | WO2005017130A2 Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof |
| 02/24/2005 | WO2005017125A2 Method for isolation and replication of infectious human hepatitis-c virus |
| 02/24/2005 | WO2005017117A2 Multipotent amniotic fetal stem cells (mafsc) and banking of same |
| 02/24/2005 | WO2005017116A2 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 02/24/2005 | WO2005017115A2 Cord blood-derived hematopoietic progenitor cells |
| 02/24/2005 | WO2005016960A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | WO2005016950A1 Methods for humanizing rabbit monoclonal antibodies |
| 02/24/2005 | WO2005016367A1 Therapeutic preparation for hematopoietic disease |
| 02/24/2005 | WO2005016283A2 Peptides for enhanced cell attachment and growth |
| 02/24/2005 | WO2005016250A2 Cell therapy for neurometabolic disorders |
| 02/24/2005 | WO2005016114A2 Generation of living tissue constructs in vivo using a mold |
| 02/24/2005 | WO2004049914A3 Methods for reacting an antigen masking compound with red blood cells with high efficiency |
| 02/24/2005 | WO2004048523A3 Modulation of ku86 expression |
| 02/24/2005 | WO2004047620A3 Fixation method for bioprostheses |
| 02/24/2005 | WO2004033673A8 Production process for plant biomass and its use |
| 02/24/2005 | WO2004014939A3 Expansion of cells using thrombopoietin and anti-transforming growth factor-beta |
| 02/24/2005 | WO2003087314A3 Method for isolating and measuring proliferation of long-term label retaining cells and stem cells |
| 02/24/2005 | WO2003062381A3 Multiply-substituted protease variants |
| 02/24/2005 | WO2003061582A3 Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach |
| 02/24/2005 | WO2003059273A3 Antibody-avidin fusion proteins as cytotoxic drugs |
| 02/24/2005 | WO2003053921A3 Mutant proteinase inhibitors and uses thereof |
| 02/24/2005 | WO2003037400A3 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo |
| 02/24/2005 | WO2003018758A3 Reagents and methods for smooth muscle therapies |
| 02/24/2005 | WO2001000643A3 Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase |
| 02/24/2005 | US20050044591 Plant cell cycle genes and methods of use |
| 02/24/2005 | US20050044586 Recombinant promoter drives tissue-specific expression of heterologous nucleic acid molecule in floral organ; improved fragrance and color |
| 02/24/2005 | US20050043795 Method for constructing reconstructed skin |
| 02/24/2005 | US20050043787 Medical device with coating that promotes endothelial cell adherence |
| 02/24/2005 | US20050043530 Seminal vesicle tissue-specific promoters and uses thereof |
| 02/24/2005 | US20050043528 Enterococcus faecalis polynucleotides and polypeptides |
| 02/24/2005 | US20050043520 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/24/2005 | US20050043516 TACI antibodies and uses thereof |
| 02/24/2005 | US20050043514 Monoclonal antibody recognizing phosphatidylinositol-3,4-diphosphate |
| 02/24/2005 | US20050043511 G-protein coupled receptor lustr2 and uses thereof |
| 02/24/2005 | US20050043260 cardiomyocyte differentiation from a non-cardiomyocyte cell; cardiac specific polynucleotide selected from Nkx2.5, GATA4, MEF2C, Tbx5, CRIPTO, NODAL, and cardiac myosin heavy chain |
| 02/24/2005 | US20050043243 Polypeptide for use in treatment of energy balance defects, energy balance involving energy metabolism, nutritional state, lipid storage and the like, food intake and metabolism of carbohydrates and lipids to generate energy |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050043198 A related nucleic acid, expression vector, host cell, and protein, the protein having a common epitope with the protease; the protease acts as an unspecific endopeptidase; cleaners also contain an amylase, cellulase, hemicellulase, oxidoreductase, or lipase; cosmetics |
| 02/24/2005 | US20050042754 Induction of the formation of insulin-producing cells via gene transfer of pancreatic beta-cell-associated transcriptional factor |
| 02/24/2005 | US20050042752 Methods of inducing gene expression |
| 02/24/2005 | US20050042751 Generation and use of new types of dendritic cells |
| 02/24/2005 | US20050042750 Methods and cell cultures for promoting organogenesis and tissue development |
| 02/24/2005 | US20050042749 Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease |
| 02/24/2005 | US20050042748 Methods for inducing differentiation of pluripotent cells |
| 02/24/2005 | US20050042746 Propagating sertoli cells in nutrient broth and generating and recovering tissue capable of assembly, propagation and maturation of afunctional artificial tissues; regenerative medicine and tissue engineering; treating diabetes |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042729 Expression vector comprising nucleotide sequences conding immunoglobulin/interferon fusion for use in targeting and treatment of liver disorders |
| 02/24/2005 | US20050042727 UDP-N-acetylglucosamine: galactose-Beta 1,3-N-A-acetylgalactosamine-alpha-R/N-acetylglucosamine-Beta 1,3-N-acetylgalactosamine-alpha-R (GIcNAc to GalNac) Beta 1,6-N-acetylglucosaminyltransferase, C2/4GnT |
| 02/24/2005 | US20050042724 Sodium-dependent phosphate cotransporter (NAPTR) for use tool in identifying modulators for treatment and prevention of cell proliferative, nervous system and cardiovascular disorders |
| 02/24/2005 | US20050042721 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | US20050042718 Using transgenic cells to generate monoclonal antibodies for use in immunodiagnostics and tissue directed therapy |
| 02/24/2005 | US20050042697 Generating trangenic cell for use as diagnostic tool in blood group determination |
| 02/24/2005 | US20050042680 Single chain antigen-binding polypeptides for polymer conjugation |
| 02/24/2005 | US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases |
| 02/24/2005 | US20050042659 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 02/24/2005 | US20050042655 Using hematopoietoic regulatory related polypeptide (HEMA) for use in diagnosis, treatment and prevention of hematopoietic disorders |
| 02/24/2005 | US20050042653 Human transport protein homologs |
| 02/24/2005 | US20050042646 RNA interference suppresion of neurodegenerative diseases and methods of use thereof |
| 02/24/2005 | US20050042637 Pax-encoding vector and use thereof |
| 02/24/2005 | US20050042634 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
| 02/24/2005 | US20050042595 Banking of multipotent amniotic fetal stem cells |
| 02/24/2005 | US20050042272 Vesiles derived from t cells, production and uses |